HAEMATO Dividends and Buybacks

Dividend criteria checks 3/6

HAEMATO is a dividend paying company with a current yield of 7.14% that is well covered by earnings.

Key information

7.1%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yield	n/a
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	€1.200
Payout ratio	64%

Recent dividend and buyback updates

No updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Too early to tell whether 0VZ7's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 0VZ7's dividend payments are increasing as they only just started paying a dividend.

Dividend Yield vs Market

HAEMATO Dividend Yield vs Market

How does 0VZ7 dividend yield compare to the market?
Segment	Dividend Yield
Company (0VZ7)	7.1%
Market Bottom 25% (GB)	2.1%
Market Top 25% (GB)	5.8%
Industry Average (Healthcare)	2.1%
Analyst forecast (0VZ7) (up to 3 years)	n/a

Notable Dividend: 0VZ7's dividend (7.14%) is higher than the bottom 25% of dividend payers in the UK market (2.01%).

High Dividend: 0VZ7's dividend (7.14%) is in the top 25% of dividend payers in the UK market (5.52%)

Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (64%), 0VZ7's dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Insufficient data to calculate 0VZ7's cash payout ratio to determine if its dividend payments are covered by cash flows.

Discover strong dividend paying companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/07/08 10:51
End of Day Share Price	2024/04/10 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HAEMATO AG is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Acklin	First Berlin Equity Research GmbH
Cosmin Filker	GBC AG
Christian Ehmann	Warburg Research GmbH